Line Dufresne

1.7k total citations · 1 hit paper
26 papers, 814 citations indexed

About

Line Dufresne is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Line Dufresne has authored 26 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Line Dufresne's work include Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Cardiac Valve Diseases and Treatments (4 papers). Line Dufresne is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Cardiac Valve Diseases and Treatments (4 papers). Line Dufresne collaborates with scholars based in Canada, United States and Iceland. Line Dufresne's co-authors include Séverine Vermeire, Gary Wild, George Thanassoulis, James C. Engert, Albert Cohen, Alain Bitton, Maida Sewitch, Pierre Paré, Alain Bitton and M Edwardes and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Gut.

In The Last Decade

Line Dufresne

23 papers receiving 797 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention

2024 40 citations Allan D. Sniderman, Line Dufresne et al. European Heart Journal profile →

Peers

Countries citing papers authored by Line Dufresne

Since Specialization

Citations

This map shows the geographic impact of Line Dufresne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Dufresne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Dufresne more than expected).

Fields of papers citing papers by Line Dufresne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Dufresne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Dufresne. The network helps show where Line Dufresne may publish in the future.

Co-authorship network of co-authors of Line Dufresne

This figure shows the co-authorship network connecting the top 25 collaborators of Line Dufresne. A scholar is included among the top collaborators of Line Dufresne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Dufresne. Line Dufresne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk 2025 ·Journal of clinical lipidology ·(unknown), (unknown), Elias Björnson, John T. Wilkins, Martin Bødtker Mortensen, Line Dufresne, Karol M. Pencina, Michael J. Pencina, George Thanassoulis, Allan D. Sniderman	2
2	Plasma Proteomic Assessment of Calcific Aortic Valve Disease in Older Adults 2025 ·Journal of the American Heart Association ·Anna E. Bortnick, Thomas R. Austin, (unknown), Valborg Guðmundsdóttir, Valur Emilsson, Lori L. Jennings, Vilmundur Guðnason, David S. Owens, Daniele Massera, Line Dufresne, Ta‐Yu Yang, James C. Engert, George Thanassoulis, Russell P. Tracy, Robert E. Gerszten, Bruce M. Psaty, Jorge R. Kizer	0
3	Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention breakdown → 2024 ·European Heart Journal ·Allan D. Sniderman, Line Dufresne, Karol M. Pencina, (unknown), George Thanassoulis, Michael Pencina	40
4	Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles? 2023 ·Journal of clinical lipidology ·(unknown), Karol M. Pencina, Michael Pencina, Line Dufresne, George Thanassoulis, Allan D. Sniderman	9
5	An adverse lipoprotein phenotype—hypertriglyceridaemic hyperapolipoprotein B—and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study 2022 ·The Lancet Healthy Longevity ·Karol M. Pencina, Michael Pencina, Line Dufresne, Michael V. Holmes, George Thanassoulis, Allan D. Sniderman	4
6	A Comparison of Lipids and apoB in Asian Indians and Americans 2021 ·Global Heart ·Kavita Singh, George Thanassoulis, Line Dufresne, Albert Nguyen, Ruby Gupta, KM Venkat Narayan, Nikhil Tandon, Allan D. Sniderman, Dorairaj Prabhakaran	10
7	Bioactive Scaffolds in Stem Cell-Based Therapies for Myocardial Infarction: a Systematic Review and Meta-Analysis of Preclinical Trials 2021 ·Stem Cell Reviews and Reports ·(unknown), Karina Gasbarrino, (unknown), Line Dufresne, Stella S. Daskalopoulou, Adel Schwertani, (unknown)	9
8	Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models 2018 ·Systematic Reviews ·(unknown), Karina Gasbarrino, (unknown), (unknown), Bin Yu, Line Dufresne, Stella S. Daskalopoulou, Adel Schwertani, (unknown)	14
9	Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium 2018 ·The American Journal of Cardiology ·Seamus P. Whelton, Andreas C. Mauer, Karol M. Pencina, Joseph M. Massaro, Ralph B. D’Agostino, Caroline S. Fox, Udo Hoffmann, Erin D. Michos, Gina M. Peloso, Line Dufresne, James C. Engert, Sekar Kathiresan, Matthew J. Budoff, Wendy S. Post, George Thanassoulis, Christopher J. O’Donnell	2
10	Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification 2017 ·Journal of the American College of Cardiology ·Mehdi Afshar, Kevin Luk, Ron Do, Line Dufresne, David S. Owens, Tamara B. Harris, Gina M. Peloso, Kathleen F. Kerr, Quenna Wong, Albert V. Smith, Matthew J. Budoff, Jerome I. Rotter, L. Adrienne Cupples, Stephen S. Rich, James C. Engert, Vilmundur Guðnason, Christopher J. O’Donnell, Wendy S. Post, George Thanassoulis	25
11	Association of LPA Variants With Aortic Stenosis 2017 ·JAMA Cardiology ·Hao Yu Chen, Line Dufresne, Hermann Burr, (unknown), (unknown), Kevin Luk, Dilrini K. Ranatunga, Rachel A. Whitmer, Mark Lathrop, James C. Engert, George Thanassoulis	43
12	Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary Syndromes 2016 ·Arteriosclerosis Thrombosis and Vascular Biology ·Waseem Hindieh, Louise Pilote, Asim N. Cheema, (unknown), Christopher Labos, Line Dufresne, James C. Engert, George Thanassoulis	33
13	Screening Strategies and Primary Prevention Interventions in Relatives of People With Coronary Artery Disease: A Systematic Review and Meta-analysis 2015 ·Canadian Journal of Cardiology ·Michael Goldfarb, (unknown), Line Dufresne, James M. Brophy, Allan D. Sniderman, George Thanassoulis	9
14	Pathway analysis for genetic association studies: to do, or not to do? That is the question 2014 ·BMC Proceedings ·Line Dufresne, Karim Oualkacha, Vincenzo Forgetta, Celia M.T. Greenwood	2
15	Abstract 47: Genetically Elevated Low-Density Lipoprotein Cholesterol is Associated with Aortic Valve Calcification and Incident Aortic Stenosis 2014 ·Circulation ·George Thanassoulis, Kevin Luk, (unknown), James C. Engert, David S. Owens, Ron Do, George Hindy, Gull Rukh, Line Dufresne, (unknown), Stephen S. Rich, Sekar Kathiresan, Marju Orho‐Melander, Vilmundur Guðnason, Christopher J. O’Donnell, Wendy S. Post, J. G. Smith	0
16	Peripheral Circadian Clocks—A Conserved Phenotype? 2013 ·Chronobiology International ·Yuval Weigl, Valerie L. Harbour, Barry Robinson, Line Dufresne, Shimon Amir	8
17	Predicting relapse in Crohn’s disease: a biopsychosocial model 2008 ·Gut ·Alain Bitton, Patricia L. Dobkin, M Edwardes, Maida Sewitch, Jon Meddings, Shristi Rawal, A Cohen, Séverine Vermeire, Line Dufresne, Denis Franchimont, Gary Wild	198
18	Tumor Necrosis Factor Receptor Gene Polymorphisms in Crohn's Disease: Association with Clinical Phenotypes 2005 ·The American Journal of Gastroenterology ·Kevin Waschke, Alexandra–Chloé Villani, Séverine Vermeire, Line Dufresne, (unknown), Alain Bitton, Albert Cohen, A. B. R. Thomson, Gary Wild	58
19	CARD15 Genetic Variation in a Quebec Population: Prevalence, Genotype-Phenotype Relationship, and Haplotype Structure 2002 ·The American Journal of Human Genetics ·Séverine Vermeire, Gary Wild, (unknown), (unknown), Line Dufresne, Alain Bitton, Diane Langelier, Pierre Paré, Gilles Lapointe, Albert Cohen, Mark J. Daly, John D. Rioux	221
20	Efficacy of an Insulin-Like Growth Factor-Interleukin-3 Fusion Protein in Reversing the Hematopoietic Toxicity Associated with Azidothymidine in Mice 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Marcos R. DiFalco, Line Dufresne, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact